DK1103252T3 - Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf - Google Patents

Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1103252T3
DK1103252T3 DK99931261T DK99931261T DK1103252T3 DK 1103252 T3 DK1103252 T3 DK 1103252T3 DK 99931261 T DK99931261 T DK 99931261T DK 99931261 T DK99931261 T DK 99931261T DK 1103252 T3 DK1103252 T3 DK 1103252T3
Authority
DK
Denmark
Prior art keywords
compound
coat
activity
preparation
pharmaceutical composition
Prior art date
Application number
DK99931261T
Other languages
Danish (da)
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1103252(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada filed Critical Liconsa Liberacion Controlada
Application granted granted Critical
Publication of DK1103252T3 publication Critical patent/DK1103252T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK99931261T 1998-07-21 1999-07-20 Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf DK1103252T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
DK1103252T3 true DK1103252T3 (da) 2003-07-14

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99931261T DK1103252T3 (da) 1998-07-21 1999-07-20 Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf

Country Status (31)

Country Link
US (1) US6737082B1 (cs)
EP (1) EP1103252B1 (cs)
JP (1) JP4190732B2 (cs)
KR (1) KR100572135B1 (cs)
AT (1) ATE234077T1 (cs)
AU (1) AU750730B2 (cs)
BG (1) BG65187B1 (cs)
BR (1) BR9912300A (cs)
CA (1) CA2337509C (cs)
CZ (1) CZ291938B6 (cs)
DE (1) DE69905905T2 (cs)
DK (1) DK1103252T3 (cs)
EE (1) EE04415B1 (cs)
ES (2) ES2157731B1 (cs)
HK (1) HK1037531A1 (cs)
HR (1) HRP20010128B1 (cs)
HU (1) HU228895B1 (cs)
IL (1) IL140910A (cs)
ME (1) MEP26708A (cs)
MX (1) MXPA01000681A (cs)
NO (1) NO320054B1 (cs)
NZ (1) NZ509886A (cs)
PL (1) PL194740B1 (cs)
PT (1) PT1103252E (cs)
RS (1) RS50063B (cs)
RU (1) RU2209628C2 (cs)
SK (1) SK283279B6 (cs)
TR (1) TR200100177T2 (cs)
UA (1) UA64009C2 (cs)
WO (1) WO2000004881A1 (cs)
ZA (1) ZA200101293B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0877563T3 (da) * 1996-01-31 2004-07-26 Univ South Alabama Levnedsmiddel- og vitaminpræparater, der indeholder den naturlige isomer af reducerede folater
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
PT1438961E (pt) * 2003-01-14 2007-05-31 Cimex Pharma Ag Composição bioquivalente de itraconazol disperso num polímero hidrofílico.
EP1438960B2 (en) * 2003-01-14 2012-12-19 Acino Pharma AG Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
DK1648467T3 (en) * 2003-07-17 2018-06-25 Janssen Sciences Ireland Uc PROCEDURE FOR MANUFACTURING PARTICLES CONTAINING AN ANTIVIRUS AGENT
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP2404602A1 (en) 2005-08-22 2012-01-11 The Johns Hopkins University Hedgehog pathway antagonists to treat cancer
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
CA2987177A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once-daily oral pharmaceutical composition of isotretinoin
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE69726729T2 (de) * 1996-05-20 2004-12-02 Janssen Pharmaceutica N.V. Fungizide mittel mit verbesserter bioverfügbarkeit
ZA974428B (en) * 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
TR199802718T2 (xx) * 1996-06-28 1999-03-22 Schering Corporation Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im.
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
EE03904B1 (et) * 1997-03-26 2002-12-16 Janssen Pharmaceutica N.V. Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid

Also Published As

Publication number Publication date
UA64009C2 (en) 2004-02-16
DE69905905T2 (de) 2004-03-04
NZ509886A (en) 2002-09-27
MEP26708A (en) 2010-06-10
CZ2001175A3 (en) 2001-05-16
US6737082B1 (en) 2004-05-18
ES2194480T3 (es) 2003-11-16
SK862001A3 (en) 2001-08-06
RS50063B (sr) 2009-01-22
PL345625A1 (en) 2002-01-02
CA2337509A1 (en) 2000-02-03
RU2209628C2 (ru) 2003-08-10
ES2157731B1 (es) 2002-05-01
AU750730B2 (en) 2002-07-25
IL140910A (en) 2004-03-28
WO2000004881A1 (es) 2000-02-03
KR100572135B1 (ko) 2006-04-19
HRP20010128A2 (en) 2002-12-31
BG105282A (en) 2001-11-30
NO20010289L (no) 2001-03-07
JP2002521323A (ja) 2002-07-16
NO320054B1 (no) 2005-10-17
CZ291938B6 (cs) 2003-06-18
TR200100177T2 (tr) 2001-07-23
PT1103252E (pt) 2003-07-31
JP4190732B2 (ja) 2008-12-03
EE200100041A (et) 2002-06-17
EP1103252B1 (en) 2003-03-12
CA2337509C (en) 2005-12-27
BR9912300A (pt) 2001-04-17
ZA200101293B (en) 2001-08-21
ATE234077T1 (de) 2003-03-15
YU3901A (sh) 2003-08-29
HRP20010128B1 (en) 2003-12-31
IL140910A0 (en) 2002-02-10
ES2157731A1 (es) 2001-08-16
HUP0103708A3 (en) 2002-07-29
AU4782199A (en) 2000-02-14
EP1103252A1 (en) 2001-05-30
SK283279B6 (sk) 2003-05-02
HK1037531A1 (en) 2002-02-15
DE69905905D1 (de) 2003-04-17
HUP0103708A2 (hu) 2002-02-28
BG65187B1 (bg) 2007-06-29
NO20010289D0 (no) 2001-01-17
PL194740B1 (pl) 2007-06-29
HU228895B1 (en) 2013-06-28
EE04415B1 (et) 2005-02-15
KR20010070990A (ko) 2001-07-28
MXPA01000681A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
DK1103252T3 (da) Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf
ATE357938T1 (de) Antibiotische hydrophile beschichtung
CA2322875A1 (en) A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
PT824344E (pt) Composicao de revestimento em po para revestimento electrostatico de substratos farmaceuticos
CA2146680A1 (en) Cleaning wafer substrates of metal contamination while maintaining wafer smoothness
FI101344B1 (fi) Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
BR9915087A (pt) Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
DE60006504D1 (de) Aufbringung von substanzen auf feste gegenstände im in-line verfahren
DE3882461D1 (de) Retroreflektierendes ueberzugsmittel und zusammensetzung zu seiner herstellung.
DE69100670T2 (de) Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel.
IT9022088A0 (it) 1,3-bis(3-(mono o poliidrossi)acilamino-5-(mono o poliirossi-al-chil)aminocarbonil-2,4,6-triiodo-benzoil-amino)-idrossi- o idrossi-alchil-propani, loro metodo di preparazione e mezzi di contrasto roentgenografici che li contengono.
AU2307402A (en) Microgranules based on active principle and method for making same
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
IE900391L (en) N-(3-pyridyl) guanidine derivative
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
HUP0203310A2 (hu) Benzimidazolszármazékot tartalmazó stabil gyógyszerkészítmények és eljárás ezek előállítására
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ITRM940715A0 (it) Nuovi 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizione farmaceutiche che li contengono
ATE4902T1 (de) Methyl-(5-(2-thienylhydroxymethyl)-1hbenzimidazol-2-yl)-carbamat, verfahren zu seiner herstellung und es enthaltende zusammensetzungen.
YU31302A (sh) Flaster za produženo lečenje bubuljica i postupak dobijanja